All Topic Areas
1 - 10 of 108 more >>
Articles
1 - 5 of 7 more >>
- Pancreatic Islet Transplantation
The pancreas, an organ about the size of a hand, is located behind the lower part of the stomach. It makes insulin and enzymes that help the body digest and use food. Spread all over the pancreas are clusters of cells called the islets of Langerhans. Islets are made up of two types of cells: alpha cells, which make glucagon, a hormone that raises the level of glucose (sugar) in the blood, and beta cells, which make insulin. Islet Functions Insulin is a hormone that helps the body use glucose...
National Institute of Diabetes and Digestive and Kidney Diseases
- Pancreatic Cancer Treatment
Recurrent pancreatic cancer is cancer that has recurred (come back) after it has been treated. The cancer may come back in the pancreas or in other parts of the body. Treatment of recurrent pancreatic cancer may include the following: Chemotherapy. Palliative surgery or stent placement to bypass blocked areas in ducts or the small intestine. Palliative radiation therapy. Other palliative medical care to reduce symptoms, such as nerve blocks to relieve pain. Clinical trials of chemotherapy or...
National Cancer Institute
- Islet Cell Carcinoma (Pancreatic) Treatment
Treatment may be one of the following: Surgery to remove the cancer. Surgery to remove the stomach (gastrectomy). Surgery to cut the nerve that stimulates the pancreas. Chemotherapy. Hormone therapy. Hepatic arterial occlusion or embolization to kill cancer cells growing in the liver. Treatment may be one of the following: Surgery to remove the cancer. Chemotherapy. Hormone therapy. Drugs to relieve symptoms. Hepatic arterial occlusion or embolization to kill cancer cells growing in the liver....
National Cancer Institute
- Genes and Disease: Pancreatic cancer
The pancreas is responsible for producing the hormone insulin, along with other substances. It also plays a key role in the digestion of protein. There were an estimated 27,000 new cases of pancreatic cancer in the US in 1997, with 28,100 deaths from the disease. About 90% of human pancreatic carcinomas show a loss of part of chromosome 18. In 1996, a possible tumor suppressor gene, DPC4 (Smad4), was discovered from the section that is lost in pancreatic cancer, so may play a role in pancreatic...
National Center for Biotechnology Information
- Pancreatic Cancer Treatment
Recurrent pancreatic cancer is cancer that has recurred (come back) after it has been treated. The cancer may come back in the pancreas or in other parts of the body. Treatment of recurrent pancreatic cancer may include the following: Chemotherapy. Palliative surgery or stent placement to bypass blocked areas in ducts or the small intestine. Palliative radiation therapy. Other palliative medical care to reduce symptoms, such as nerve blocks to relieve pain. Clinical trials of chemotherapy or...
National Cancer Institute
News
1 - 5 of 563 more >>
- Enzyme Finding Sheds Light On How Memories Are Made And What Goes Wrong In Brain Disorders
ScienceDaily - Fri, 02 Mar 2007 04:00 EST
- Type 1 diabetes linked to pancreatic cancer risk
Reuters - Thu, 01 Mar 2007 05:24 EST
- An enzyme may keep aneurysms from growing
The Earth Times - Mon, 19 Feb 2007 05:47 EST
- Threshold Pharmaceuticals Announces That A Phase 3 Clinical Trial Of Glufosfamide For Treatment Of Pancreatic Cancer Did Not Meet Its Primary Endpoint
MedicalNewsToday - Tue, 27 Feb 2007 08:00 EST
- Opening And Closing The Genome: Newly Identified Enzyme Orchestrates Access To Genes For ...
ScienceDaily - Fri, 23 Feb 2007 04:00 EST
Clinical Trials
1 - 5 of 1022 more >>
- 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00064051 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
- Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00095966 - Active, not recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
- Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00068432 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00114244 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00077519 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer

Not Signed In -

